$HROW

HARROW, INC. (HROW): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

HARROW, INC. (HROW) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Effective September 4, 2026, Randall E. Pollard ceased serving as Chief Accounting Officer and principal accounting officer

Original reporting
Published Sep 4, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 8:47 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$HROW
Neutral
medium confidence
Mentioned
$HROW
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HROWNeutralLow
01

Why it matters

The filing provides the first public notice of the leadership change, which may influence short‑term stock movement.

02

Market read

Primary corporate action filing with modest trading relevance.

03

What to watch

Potential impact on internal controls and future audit outcomes.

Relevance 6/10Novelty 5/10Timing: effective September 4, 2026

Background

Harrow, Inc. (HROW) filed an 8‑K announcing an executive departure and internal appointment.

Company-level read

Ticker impact

$HROWNeutralMedium confidence
Context

SEC Form 8‑K reports the departure of CAO Randall Pollard and appointment of CFO Andrew Boll as principal accounting officer.

Expected impact

Minor short‑term volatility expected; no clear directional bias.

Evidence & confidence

Executive turnover is material for governance but no compensation change or strategic shift disclosed.

Market effects

Limited impact on the broader sector; similar filings are routine.

No regional effect beyond Harrow's shareholder base.

Not globally relevant.

Counterpoint

The change could signal deeper governance issues not yet disclosed.

Key entities

  • Harrow, Inc.

    US‑listed firm reporting the executive change.

  • Randall E. Pollard

    Departing Chief Accounting Officer.

  • Andrew R. Boll

    Current President & CFO appointed as principal accounting officer.

Related articles

$HROWMedAI 8/10

What's Going On With Harrow Stock Friday? - Harrow (NASDAQ:HROW)

Harrow Inc. (NASDAQ:HROW) reported positive results from a clinical study of its ocular anesthetic IHEEZO, showing significant pain reduction compared to a control. Analysts noted the findings support long-term growth and maintained an Outperform rating. HROW shares were down 1.33% at $41.50 on Friday.

$HROWMed

Harrow (HROW): Strong Product Momentum Meets A Steep H2 Revenue Target

Harrow Inc. (HROW) reported H1 2026 revenue of $115M, below expectations, but reaffirmed its full-year guidance of $350M-$365M. Key products IHEEZO, VEVYE, and TRIESENCE showed strong growth, but the company faces a steep H2 revenue target. Harrow also announced a pending deal for TYRVAYA, expected to add $30M in 2027 revenue. Adjusted EBITDA was negative $1.2M for the quarter, and the company has $83.9M in cash.

$HROWMed

Harrow Q2 Earnings Call Highlights

Harrow (NASDAQ:HROW) reported Q2 revenue of $15.6M for IHEEZO, with demand up to 65,477 units (+44% sequential, +34% YoY) but revenue lagging due to distributor sell-through of prior inventory. Management cited normalized channel inventory, ~25% higher net pricing effective July 1, gross margin 71%, and cash of $83.9M. Harrow also discussed BYOOVIZ launch, VEVYE PBM coverage, and a pending TYRVAYA acquisition.

$HROWMed

HARROW, INC. (HROW): Results of Operations and Financial Condition

HARROW, INC. (HROW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Harrow Announces Second Quarter 2026 Financial Results Second Quarter 2026 and Selected Highlights: ● Quarterly revenue of $70.7 million, an increase of 60% sequentially, and 11% year over year ● Reiterated full-year 2026 financial guidance of $350 million to $365 mi